Annular Pancreas

Search Trials
Daily Imaging, Target Identification, and Simulated Computed Tomography-Based Stereotactic Adaptive Radiotherapy Workflow in a Novel Ring Gantry Radiotherapy Device
Status:
Active, not recruiting
Last Changed:
Feb 28, 2022
First Changed:
Jul 5, 2019
Disease(s):
Cancer of Pancreas
Intervention(s):
Ring gantry kV-CBCT combined with linear accelerator
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Status:
Recruiting
Last Changed:
Feb 17, 2022
First Changed:
Mar 18, 2019
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Intervention(s):
AbemaciclibAbirateroneAfatinibBevacizumabBicalutamideBiospecimen CollectionBortezomibCabazitaxelCabozantinibCapecitabineCarboplatinCelecoxibCobimetinibCopanlisibDabrafenibDacomitinibDarolutamideDasatinibDoxorubicinDurvalumabEnasidenibEnzalutamideErlotinibEverolimusFluorouracilIdelalisibImatinibIpilimumabLenvatinibLeucovorinLorlatinibLosartanNab-paclitaxelNeratinibNivolumabOlaparibOxaliplatinPalbociclibPanobinostatPembrolizumabPertuzumabPonatinibQuality-of-Life AssessmentRegorafenibRuxolitinibSirolimusSorafenibSunitinibTrametinibTrastuzumab EmtansineTretinoinVemurafenibVenetoclaxVismodegibVorinostat
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Dec 21, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Gene Therapy in Treating Patients With Cancer
Status:
Completed
Last Changed:
Jun 10, 2011
First Changed:
Apr 19, 2004
Disease(s):
Cancer
Intervention(s):
therapeutic autologous lymphocytes

Connect. Empower. Inspire.